<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05089578</url>
  </required_header>
  <id_info>
    <org_study_id>Amasya U-2</org_study_id>
    <nct_id>NCT05089578</nct_id>
  </id_info>
  <brief_title>Integrative Treatment Methods in COVID-19</brief_title>
  <official_title>Examination of the Use of Integrative Treatment Methods by Individuals Undergoing COVID-19 Acording to the Health Promotion Model: a Sample Qualitative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amasya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amasya University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was conducted to examine the use of integrative treatment methods by individuals&#xD;
      undergoing Covid-19. In this study, which was designed in the qualitative and&#xD;
      phenomenological type, the criterion sampling method was used and 12 people were included in&#xD;
      the sample.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was a qualitative type of phenomenological study conducted to examine the use of&#xD;
      integrative treatment methods by individuals undergoing Covid-19. The study was completed&#xD;
      with 12 people. The data were collected between July and October 2021. The interviews lasted&#xD;
      for an average of 25-30 minutes. The data collected with the semi-structured interview form&#xD;
      were analyzed by descriptive content analysis method after the interviews were over.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2021</start_date>
  <completion_date type="Actual">October 15, 2021</completion_date>
  <primary_completion_date type="Actual">October 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Using integrative treatment method</measure>
    <time_frame>15 July- October 2021</time_frame>
    <description>All participants included in the study had used at least one of the integrative treatment methods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kind of integrative treatment methods</measure>
    <time_frame>October 2021</time_frame>
    <description>It was determined that vitamin C and medicinal plants were frequently used in addition to their medical treatments.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>COVID-19</condition>
  <condition>Patient Experience</condition>
  <condition>Health Attitude</condition>
  <arm_group>
    <arm_group_label>Individuals with Covid-19</arm_group_label>
    <description>Interviews were conducted with individuals who had Covid-19, and their experiences with the integrative methods they used were determined.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>focus interview</intervention_name>
    <description>The &quot;Information Form&quot; including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured &quot;Interview Form&quot;, and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.</description>
    <arm_group_label>Individuals with Covid-19</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals who underwent Covid-19 and used any of the integrative treatment methods&#xD;
        constituted the population of the study. Using the criterion sampling method, individuals&#xD;
        who underwent Covid-19 and used any of the integrative treatment methods and agreed to&#xD;
        participate in the study constituted the sample group. In accordance with the nature of&#xD;
        qualitative research, the study was completed with 12 people.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  individuals who underwent Covid-19 and used any of the integrative treatment methods&#xD;
&#xD;
          -  agreed to participate in the study constituted the sample group.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gamze Fıskın, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amasya University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nurhan Dogan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amasya University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Amasya University Sciences Faculty</name>
      <address>
        <city>Amasya</city>
        <zip>05100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Amasya University</investigator_affiliation>
    <investigator_full_name>nurhandogan</investigator_full_name>
    <investigator_title>Asisst.Prof.</investigator_title>
  </responsible_party>
  <keyword>Covid-19</keyword>
  <keyword>patient experince</keyword>
  <keyword>integrative treatment</keyword>
  <keyword>qualitative study</keyword>
  <keyword>health promotion model</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

